Eckert & Ziegler to Recommend Dividend Payment
Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Dividend
17.03.2015 19:29
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Ad-hoc disclosure in compliance with §15 WpHG
ISIN DE 0005659700
Eckert & Ziegler to Recommend Dividend Payment
Berlin, March 17, 2015. The company Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700) increased its sales by 9 % to EUR 127 million in fiscal year 2014. As the Supervisory Board stated at its balance sheet meeting held today, net profit for the year was EUR 1.28 per share, or EUR 6.8 million in total (prior year: EUR 1.71 per share and EUR 9.0 million). The decline in earnings was mainly due to the Radiation Therapy segment, which earned EUR 0.91 per share less than in the prior year.
At the Annual General Meeting on June 3, 2015, the Executive Board and the Supervisory Board will propose a dividend of EUR 0.60 per share entitled to a dividend (prior year: EUR 0.60 per share). The complete figures will be published on March 26, 2015.
For enquiries please contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.com
17.03.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English
Company: Eckert & Ziegler Strahlen- und Medizintechnik AG Robert-Rössle-Str.10
13125 Berlin
Germany
Phone: 49 30 941084-138
Fax: 49 30 941084-112
E-mail: karolin.riehle@ezag.de
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Listed: Regulated Market in Frankfurt (Prime Standard), Stuttgart; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich
End of Announcement DGAP News-Service